John M. Goldberg
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Public Health, Environmental and Occupational Health top 10%
- Molecular Biology
- Genetics top 10%
- Co-authors
- Jeffrey CrawfordJames KhatcheressianThomas J. SmithKari BohlkeGary H. LymanJames L. WadeNatasha B. LeighlKenneth R. Carson
- Topics
- Immunotherapy and Immune Responses (7 papers)Cancer Immunotherapy and Biomarkers (6 papers)CAR-T cell therapy research (5 papers)
- Cited by
- OncologyHematologyDermatology
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
John M. Goldberg
25 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 711
- Pulmonary and Respiratory Medicine 285
- Public Health, Environmental and Occupational Health 235
- Molecular Biology 212
- Genetics 192
Countries citing papers authored by John M. Goldberg
This map shows the geographic impact of John M. Goldberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Goldberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Goldberg more than expected).
Fields of papers citing papers by John M. Goldberg
This network shows the impact of papers produced by John M. Goldberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Goldberg. The network helps show where John M. Goldberg may publish in the future.
Co-authorship network of co-authors of John M. Goldberg
This figure shows the co-authorship network connecting the top 25 collaborators of John M. Goldberg. A scholar is included among the top collaborators of John M. Goldberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Goldberg. John M. Goldberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 4 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | From vision to reality: deploying the immune system for treatment of sarcoma. | 7 |
| 7 | 1 | |
| 8 | 47 | |
| 9 | Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Updatebreakdown → | 589 |
| 10 | Immunotherapy in sarcoma: a new frontier. | 11 |
| 11 | 18 | |
| 12 | 5 | |
| 13 | 51 | |
| 14 | 1 | |
| 15 | 118 | |
| 16 | 7 | |
| 17 | 1 | |
| 18 | 12 | |
| 19 | 87 | |
| 20 | 7 |
About John M. Goldberg
John M. Goldberg is a scholar working on Immunology, Biotechnology and Oncology, having authored 25 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Oncology (711 citations), Hematology (190 citations) and Dermatology (110 citations). John M. Goldberg has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Jeffrey Crawford, James Khatcheressian, Thomas J. Smith, Kari Bohlke, Gary H. Lyman, James L. Wade, Natasha B. Leighl, Kenneth R. Carson, Antoinette J. Wozniak and Jamés O. Armitage. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.